Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

• Kara W. Chew,
• Carlee Moser,
• Eric S. Daar,
• David A. Wohl,
• Jonathan Z. Li,
• Robert W. Coombs,
• Justin Ritz,
• Mark Giganti,
• Arzhang Cyrus Javan,
• Yijia Li,
• Manish C. Choudhary,
• Rinki Deo,
• Carlos Malvestutto,
• Paul Klekotka,
• Karen Price,
• Ajay Nirula,
• William Fischer,
• Veenu Bala,
• Ruy M. Ribeiro,
• Alan S. Perelson,
• Courtney V. Fletcher,
• Joseph J. Eron,
• Judith S. Currier,
• ACTIV-2/A5401 Study Team,
• Michael D. Hughes,
• Davey M. Smith

Affiliations

Kara W. Chew

Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles

Carlee Moser

Harvard T.H. Chan School of Public Health

Eric S. Daar

Lundquist Institute at Harbor-UCLA Medical Center

David A. Wohl

Department of Medicine, University of North Carolina at Chapel Hill School of Medicine

Jonathan Z. Li

Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Robert W. Coombs

Department of Laboratory Medicine and Pathology, University of Washington

Justin Ritz

Harvard T.H. Chan School of Public Health

Mark Giganti

Harvard T.H. Chan School of Public Health

Arzhang Cyrus Javan

National Institutes of Health

Yijia Li

Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Manish C. Choudhary

Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Rinki Deo

Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Carlos Malvestutto

Ohio State University Wexner Medical Center

Paul Klekotka

Eli Lilly and Company

Karen Price

Eli Lilly and Company

Ajay Nirula

Eli Lilly and Company

William Fischer

Department of Medicine, University of North Carolina at Chapel Hill School of Medicine

Veenu Bala

UNMC Center for Drug Discovery, University of Nebraska Medical Center

Ruy M. Ribeiro

Theoretical Biology and Biophysics Group, Los Alamos National Laboratory

Alan S. Perelson

Theoretical Biology and Biophysics Group, Los Alamos National Laboratory

Courtney V. Fletcher

UNMC Center for Drug Discovery, University of Nebraska Medical Center

Joseph J. Eron

Department of Medicine, University of North Carolina at Chapel Hill School of Medicine

Judith S. Currier

Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles

ACTIV-2/A5401 Study Team

Michael D. Hughes

Harvard T.H. Chan School of Public Health

Davey M. Smith

Department of Medicine, University of California, San Diego